Colorectal (Colon or Rectal) Cancer clinical trials at UCLA

1 research study open to eligible people

Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
open to eligible people ages 18 years and up
This study will investigate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 in participants with advanced or metastatic Microsatellite Stable (MSS)/Microsatellite Instability Low (MSI-L) Colorectal Cancer
Los Angeles, California and other locations

Last updated: August 25, 2026